Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parainfluenza type 2; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parainfluenza type 2 vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine distemper virus - living; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvo virus - misc. vaccines or anti sera - canine distemper virus - living vaccine-viral active 0.0 undefined; canine parainfluenza virus vaccine-viral active 0.0 undefined; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 undefined; canine parvo virus vaccine-viral active 0.0 undefined - immunotherapy - dog | bitch | castrate | puppy - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | vaccine | equine rotavirus | parvovirus

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation; distributor: broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine parainfluenza virus (cpiv) , canine adenovirus (cav) , canine parvovirus (cpv) , inactivated leptospira interrogans icterohaemorrhagiae , leptospira interrogans canicola , leptospira vaccine (vet.) - solution for injection (im) - each ml (1 dose) contains: lyophilisate (live attenuated): canine distemper virus, strain cdv bio 11/a 103.1-5. tcid50 canine adenovirus type 2, strain cav-2 bio 13 103.6-5.3. tcid50 canine parvovirus type 2b, strain cpv-2b bio 12/b 104.3-6.6 tcid50 canine parainfluenza type 2 virus, strain cpiv-2 bio 15- 103.1:5.1 tcid50 tcid – tissue culture infectious dose suspension (inactivated): leptospira interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089 gmt 1:51 alr leptospira interrogans serogroup canicola, serovar canicola, strain mslb 1090 gmt 1:51 alr leptospira kirschneri serogroup grippotyphosa, serovar grippotyphosa, strain mslb 1091 21:40 alr leptospira interrogans serogroup australis, serovar bratislava, strain mslb 1088 gmt 1:51 alr alr - antibody micro agglutination-lytic reaction gmt-geometric mean titre

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza; leptospira icterohaemorrhagiae antigen; canine adeno virus type 2; canine coronavirus vaccine - antigen; canine distemper virus; canine parvo virus - misc. vaccines or anti sera - canine parainfluenza vaccine active 0.0 undefined; leptospira icterohaemorrhagiae antigen vaccine-antigen active 0.0 undefined; canine adeno virus type 2 vaccine-viral active 0.0 undefined; canine coronavirus vaccine - antigen vaccine-viral active 0.0 undefined; canine distemper virus vaccine-viral active 0.0 undefined; canine parvo virus vaccine-viral active 0.0 undefined - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parainfluenza | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine distemper virus - living; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvo virus type 2 - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 qs dose; canine distemper virus - living vaccine-viral active 0.0 qs dose; canine parainfluenza virus vaccine-viral active 0.0 qs dose; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 qs dose; canine parvo virus type 2 vaccine-viral active 0.0 qs dose - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parvovirus | hepatitis :- infectious | parainfluenza virus type 2 (infections) | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infections caused by parainflu | infectious canine hepatitis | infectious tracheobronchitis | parvovirus

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated canine parvovirus (cpv) , canine distemper virus (cdv) , canine adenovirus type 2 (cav 2) vaccine , inactivated leptospira interrogans ser. icterohaemorrhagiae , l. interrogans ser. canicola vaccine (vet.) - freeze dried powder for injection (sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (c-780916 strain)->10^6 tcid50 canine distemper virus (lederle strain)->10^4 tcid50 canine adenovirus type 2 (manhattan strain)->10^4 tcid50 leptospira interrogans ser. icterohaemorrhagiae->10^9 microorganisms leprospira interrogans ser. canicola toid-tissue culture infactive->10^9 microorganisms

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parainfluenza type 2; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parainfluenza type 2 vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus